Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Filippi

Showing results (121-130 of 325) with videos related to

Pageof 33
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|November 9, 2012
Usefulness of dual-time point imaging after carbonated water for the fluorodeoxyglucose positron emission imaging of peritoneal carcinomatosis in colon cancerLuca Filippi, Marco D'Arienzo, Francesco Scopinaro, et al.
EJNMMI Radiopharmacy and Chemistry|May 2, 2024
<sup>99m</sup>Tc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applicationsAlessandra Boschi, Luca Urso, Licia Uccelli, et al.
Scientific Reports|October 14, 2017
Probiotic supplementation in preterm infants does not affect the risk of retinopathy of prematurity: a meta-analysis of randomized controlled trialsGiacomo Cavallaro, Eduardo Villamor-Martínez, Luca Filippi, et al.
Pharmacological Research|March 2, 2023
The β3 adrenoceptor in proliferative retinopathies: "Cinderella" steps out of its family shadowMaurizio Cammalleri, Rosario Amato, Massimo Dal Monte, et al.
Expert Review of Anticancer Therapy|March 7, 2024
Positron emission computed tomography targeting urokinase plasminogen activator receptor (uPAR) in cancer: a systematic reviewRiccardo Camedda, Viviana Frantellizzi, Roberta Danieli, et al.
Medicinal Research Reviews|December 30, 2021
β3-Adrenoceptor, a novel player in the round-trip from neonatal diseases to cancer: Suggestive clues from embryoLuca Filippi, Alessandro Pini, Maurizio Cammalleri, et al.
Dermatologic Therapy|January 3, 2021
The potential role of propranolol in incontinentia pigmentiTeresa Oranges, May El Hachem, Cesare Filippeschi, et al.
Progress in Retinal and Eye Research|June 17, 2014
The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseasesGiovanni Casini, Massimo Dal Monte, Irene Fornaciari, et al.
Frontiers in Pediatrics|November 29, 2023
Neonatal hypoxic-ischemic encephalopathy after acute carbon monoxide intoxication during pregnancy. A case report and brief review of the literatureCristina Tuoni, Giulia Nuzzi, Rosa Teresa Scaramuzzo, et al.
Handbook of Experimental Pharmacology|November 20, 2023
β-Adrenoceptors in Cancer: Old Players and New PerspectivesRosario Amato, Martina Lucchesi, Silvia Marracci, et al.
Pageof 33

Showing results (121-130 of 325) with videos related to

Sort By:
Pageof 33
Cancer Biotherapy & Radiopharmaceuticals|November 9, 2012
Usefulness of dual-time point imaging after carbonated water for the fluorodeoxyglucose positron emission imaging of peritoneal carcinomatosis in colon cancerLuca Filippi, Marco D'Arienzo, Francesco Scopinaro, et al.
EJNMMI Radiopharmacy and Chemistry|May 2, 2024
<sup>99m</sup>Tc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applicationsAlessandra Boschi, Luca Urso, Licia Uccelli, et al.
Scientific Reports|October 14, 2017
Probiotic supplementation in preterm infants does not affect the risk of retinopathy of prematurity: a meta-analysis of randomized controlled trialsGiacomo Cavallaro, Eduardo Villamor-Martínez, Luca Filippi, et al.
Pharmacological Research|March 2, 2023
The β3 adrenoceptor in proliferative retinopathies: "Cinderella" steps out of its family shadowMaurizio Cammalleri, Rosario Amato, Massimo Dal Monte, et al.
Expert Review of Anticancer Therapy|March 7, 2024
Positron emission computed tomography targeting urokinase plasminogen activator receptor (uPAR) in cancer: a systematic reviewRiccardo Camedda, Viviana Frantellizzi, Roberta Danieli, et al.
Medicinal Research Reviews|December 30, 2021
β3-Adrenoceptor, a novel player in the round-trip from neonatal diseases to cancer: Suggestive clues from embryoLuca Filippi, Alessandro Pini, Maurizio Cammalleri, et al.
Dermatologic Therapy|January 3, 2021
The potential role of propranolol in incontinentia pigmentiTeresa Oranges, May El Hachem, Cesare Filippeschi, et al.
Progress in Retinal and Eye Research|June 17, 2014
The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseasesGiovanni Casini, Massimo Dal Monte, Irene Fornaciari, et al.
Frontiers in Pediatrics|November 29, 2023
Neonatal hypoxic-ischemic encephalopathy after acute carbon monoxide intoxication during pregnancy. A case report and brief review of the literatureCristina Tuoni, Giulia Nuzzi, Rosa Teresa Scaramuzzo, et al.
Handbook of Experimental Pharmacology|November 20, 2023
β-Adrenoceptors in Cancer: Old Players and New PerspectivesRosario Amato, Martina Lucchesi, Silvia Marracci, et al.
Pageof 33